Li D - Search Results

1

Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.

Zhang Z, Dong Z, Li J, Carr MJ, Zhuang D, Wang J, Zhang Y, Ding S, Tong Y, Li D, Shi W. Zhang Z, et al. Among authors: li d, li j. J Virol. 2017 Jun 9;91(13):e00333-17. doi: 10.1128/JVI.00333-17. Print 2017 Jul 1. J Virol. 2017. PMID: 28424287 Free PMC article.

2

Chitosan can stop or postpone the death of the suckling mice challenged with foot-and-mouth disease virus.

Li D. Li D. Virol J. 2010 Jun 12;7:125. doi: 10.1186/1743-422X-7-125. Virol J. 2010. PMID: 20540780 Free PMC article.

3

Alternative way to test the efficacy of swine FMD vaccines: measurement of pigs median infected dose (PID50) and regulation of live virus challenge dose.

Li D, Lu ZJ, Xie BX, Sun P, Chen YL, Fu YF, Liu ZX. Li D, et al. Virol J. 2010 Sep 8;7:215. doi: 10.1186/1743-422X-7-215. Virol J. 2010. PMID: 20822547 Free PMC article.

4

A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.

Zhang Z, Dong Z, Wei Q, Carr MJ, Li J, Ding S, Tong Y, Li D, Shi W. Zhang Z, et al. Among authors: li d, li j. J Virol. 2017 Apr 13;91(9):e02450-16. doi: 10.1128/JVI.02450-16. Print 2017 May 1. J Virol. 2017. PMID: 28250116 Free PMC article.

5

The rescue and selection of thermally stable type O vaccine candidate strains of foot-and-mouth disease virus.

Gao Y, Li P, Ma X, Bai X, Sun P, Du P, Yuan H, Cao Y, Li K, Fu Y, Zhang J, Bao H, Chen Y, Li Z, Lu Z, Liu Z, Li D. Gao Y, et al. Among authors: li d, li z, li k, li p. Arch Virol. 2021 Aug;166(8):2131-2140. doi: 10.1007/s00705-021-05100-3. Epub 2021 May 18. Arch Virol. 2021. PMID: 34003358

6

Development and validation of a prokaryotically expressed foot-and-mouth disease virus non-structural protein 2C'3AB-based immunochromatographic strip to differentiate between infected and vaccinated animals.

Wu L, Jiang T, Lu ZJ, Yang YM, Sun P, Liang Z, Li D, Fu YF, Cao YM, Liu XT, Liu ZX. Wu L, et al. Among authors: li d. Virol J. 2011 Apr 23;8:186. doi: 10.1186/1743-422X-8-186. Virol J. 2011. PMID: 21513550 Free PMC article.

7

Effects of two amino acid substitutions in the capsid proteins on the interaction of two cell-adapted PanAsia-1 strains of foot-and-mouth disease virus serotype O with heparan sulfate receptor.

Bai X, Bao H, Li P, Wei W, Zhang M, Sun P, Cao Y, Lu Z, Fu Y, Xie B, Chen Y, Li D, Luo J, Liu Z. Bai X, et al. Among authors: li d, li p. Virol J. 2014 Jul 24;11:132. doi: 10.1186/1743-422X-11-132. Virol J. 2014. PMID: 25056022 Free PMC article.

8

MORC3 restricts human cytomegalovirus infection by suppressing the major immediate-early promoter activity.

Ma XH, Yao YX, Wang XZ, Zhou YP, Huang SN, Li D, Mei MJ, Wu JP, Pan YT, Cheng S, Jiang X, Sun JY, Zeng WB, Gong S, Cheng H, Luo MH, Yang B. Ma XH, et al. Among authors: li d. J Med Virol. 2022 Nov;94(11):5492-5506. doi: 10.1002/jmv.28025. Epub 2022 Aug 5. J Med Virol. 2022. PMID: 35879101

9

[Enhanced immune response of a novel T-cell immunogen in vaccine for foot-and-mouth disease].

Zhao Q, Sun P, Liu Z, Li P, Bao H, Cao Y, Bai X, Fu Y, Lu Z, Li D. Zhao Q, et al. Among authors: li d, li p. Sheng Wu Gong Cheng Xue Bao. 2011 Sep;27(9):1281-91. Sheng Wu Gong Cheng Xue Bao. 2011. PMID: 22117511 Chinese.

10

The infectivity and pathogenicity of a foot-and-mouth disease virus persistent infection strain from oesophageal-pharyngeal fluid of a Chinese cattle in 2010.

Bao HF, Li D, Sun P, Zhou Q, Hu J, Bai XW, Fu YF, Lu ZJ, Liu ZX. Bao HF, et al. Among authors: li d. Virol J. 2011 Dec 14;8:536. doi: 10.1186/1743-422X-8-536. Virol J. 2011. PMID: 22166050 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52,703 results

Search Page

Filters